References

  1. Blumenthal M, Busse WR, Goldberg A, et al, eds. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications,1998, 148–149.

  2. Murray, M.T. (1999) Horse chestnut extract in chronic venous insufficiency. Natural Medicine Online, July. http://www.nat-med.com/

  3. Vanhoutte PM, et al. (1997) Venous disease: from pathophysiology to quality of life. Angiology 48(7):559-67.

  4. Bombardelli E, et al. (1996). Aesculus hippocastanum L. Fitoterapia 67:483-511.

  5. (3737) Escin in the Merck Index, Twelfth Edition, page 628.

  6. Lorenz D, Marek ML. (1960) Das therapeutische wirksame Prinzip der Rosskastanie (Aesculus hippocastanum). Arzneim- Forsch 10:263-272.

  7. Guillaume M, Padioleau. (1994). Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneim-Forsch 44:25-35.

  8. Schrader E, et al. (1995) Vergleichende Untersuchung zur Bioverfügbarkeit von ß-Aescin nach oraler Einmalverabreichung zweier Rosskastaniensamenextrakt enthaltender, galenisch unterschiedlicher Darreichungsformen. Pharmazie 50:623-627.

  9. Masaki H, et al. (1997) Effect of escins Ia, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol Pharm 20:1092-5.

  10. Facino RM, et al. (1995) Anti-elastase and anti-hyaluronidase activities of saponins and sapogenins from Hedera helix, Aesculus hippocastanum, and Ruscus aculeatus: factors contributing to their efficacy in the treatment of venous insufficiency. Arch. Pharm 328:720-24.

  11. Sarin S, et al (1993) Neutrophil activation in venous disease. J Vasc Surg 17:444.

  12. Calabrese, C. and Preston, P. (1993) Report of the results of a double-blind, randomized,single-dose trial of a topical 2% escin gel versus placebo in the acute treatment of experimentally-induced hematoma in volunteers. Planta Medica 59:394-397.

  13. Guillaume , M. and Padioleau, F. (1994) Veinotonic effect, vascular protection,anti-inflammatory and free radical scavenging properties of horse chestnut extract. Arzneim-Forsch Drug Research. 44(1): 25-35.

  14. Annoni,F. et al. (1979) Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung; 29(4):672-5.

  15. Lochs H et al. (1974) Effect of horse chestnut extracts on venous tone Arzneimittelforschung Sep; 24(9):1347-50

  16. Bonati A. (1977) Les dérivès du marronnier d'Inde dans le traitment des maladies vasculaires. Plantes Méd.Phytothér. 11: 174-80.

  17. Pittler MH, Ernst E. (1998) Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review. Arch Dermatol November; 134:1356-60.

  18. Apgar, B. (1999) Horse-Chestnut Seed Extract for Chronic Venous Insufficiency. American Family Physician, March 15, pp 1623.

  19. Diehm, G.et al (1996) Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347(8997):292-4

  20. Rehr, D. et al. (1996) Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneim-Forsch/Drug Res. 46(1):483-487.

  21. Bombardelli E., et al. (1989) "Topical Anti-Inflammatory Activity of Complexes of Escin and Sterols with Phospholipids - Part I", Fitoterapia 60, Supplemento al n. 1, 39

  22. Curri S.B., et al. (1989) "Topical Anti-Inflammatory Activity of Complexes of Escin and Sterols with Phospholipids - Part II: Anti-Oedema Properties in the Treatment of Panniculopathies of the Thighs and Breast",Fitoterapia 60, Supplemento al n. 1, 45

  23. Morgan M., and Bone K.. (1998) Aesculus hippocastanum — Horsechestnut. MediHerb Professional Review. No. 65, pp. 1-6.

  24. Hellberg K et al. (1975) Drug induced acute renal failure after heart surgery. Thoraxchir Vask Chir Aug;23(4):396-9

  25. Rothkopf M, et al. (1977) Animal experiments on the question of the renal toleration of the horse chestnut saponin aescin. Arzneimittelforschung 27(3): 598–605.

  26. Brinker F. (1998) Herb Contraindications and Drug Interactions, 2nd ed. Oregon: Eclectic Medical Publications : 84.

  27. Heck, A.M. et al (2000) Potential interactions between alternative therapies and warfarin. Am J Health-Syst Pharm. 57:1221-30

  28. Rudofsky G, Neiß A, Otto K, Seibel K. Ödemprotektive Wirkung und klinische Wirksamkeit von Roßkastaniensamenextrakt im Doppeltblindversuch. Phlebol Proktol 15:47-54, 1986.

  29. Bisler H, Pfeifer R, Klüken N, Pauschinger. Wirkung von Roßkastaniensamenextrakt auf die transkapill Šre Filtration bei chronisch venšser Insuffizienz. Dtsch med Wschr. 111:1321-29, 1986.

  30. Pilz E. Ìdeme bei Venenerkrankungen. Die Medizinische Welt 40:1143-4, 1990.

  31. Diehm C, Vollbrecht D, Amendt K, Comberg HU. Medical edema protection - Clinical benefit in patients with chronic deep vein incompetence. A placebo controlled double blind study. VASA 21:188-191, 1992.

  32. Friederich HC, Vogelsberg H, Neiss A. Ein Beitrag zur Bewertung von intern wirksamen Venenpharmaka. Z Hautkr. 53:369-74, 1978.

  33. Lohr E, Garanin G, Jesau P, Fischer H. Ödempräventive Therapie bei chronischer Veneninsuffizienz mit Ödemneigung. Münch med Wschr 128:59-81, 1986.

  34. Neiss A, Böhm C. Zum Wirksamkeitsnachweis von Roßkastaniensamenextrakt beim varikösen Symptomenkomplex. Münch med Wschr 118:213-6, 1976.

  35. Steiner M. Untersuchungen zur ödemvermindernden und ödemprotektiven Wirkung von Roßkastaniensamenextrakt. Phlebol Proktol. 19:239-42, 1990.

  36. Kalbfleisch W, Pfalzgraf H. Ödemprotektiva. Äquipotente Dosierung - Roßkastaniensamenextrakt und O-ß-Hydroxyethylrutoside im Vergleich. Therapiewoche 39:3703-7, 1989.

  37. Rehn D, Unkauf M, Klein P, Jost V, Lücker PW. Comparative clinical efficacy and tolerability of ocerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneim Forsch 46:483-7, 1996.

  38. Erdlen F. Klinische Wirksamkeit von Venostasin retard im Doppelblindversuch. Die Medizinische Welt 40:994-6, 1989.

  39. Erler M. Roßkastaniensamenextrakt bei der Therapie peripherer venöser Ödeme - ein klinischer Therapievergleich. Die Medizinische Welt. 42:593-6, 1991.

  40. Hippocastani semen (Horse-chestnut Seed) ESCOP:Monographs on the medicinal uses of plant drugs, Fascicule 6.




Disclaimer

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.